淋巴毒素
癌症免疫疗法
癌症研究
免疫疗法
CD8型
黑色素瘤
CXCL13型
淋巴毒素β受体
免疫系统
癌症
癌细胞
生物
肿瘤微环境
免疫学
趋化因子
遗传学
趋化因子受体
作者
Anthony B. Rodriguez,J. David Peske,Amber N. Woods,Katie M. Leick,Ileana Soto Mauldin,Max O. Meneveau,Samuel J. Young,Robin S. Lindsay,Marit Martina Melssen,Salwador Cyranowski,Geoffrey Parriott,Mark R. Conaway,Yang‐Xin Fu,Craig Lee Slingluff,Víctor H. Engelhard
出处
期刊:Cell Reports
[Cell Press]
日期:2021-07-01
卷期号:36 (3): 109422-109422
被引量:277
标识
DOI:10.1016/j.celrep.2021.109422
摘要
Tertiary lymphoid structures (TLS) are lymphoid aggregates resembling secondary lymphoid organs found at sites of inflammation. TLS have been identified in tumors (TA-TLS), where they are associated with enhanced patient survival, but the mechanisms underlying their formation are unknown. We show here that TA-TLS development in murine melanomas is orchestrated by fibroblasts with characteristics of lymphoid tissue organizer cells that are induced by tumor necrosis factor receptor signaling. Fibroblast organization into reticular networks is initiated by CD8 T-cells, but full TA-TLS development depends on CXCL13-mediated recruitment of B-cells that express lymphotoxin-α1/β2. Some of these elements were also overrepresented in TA-TLS of human tumors. Immune checkpoint blockade induced more and larger TA-TLS that were more often organized with discrete T- and B-cell zones. This work provides a platform for manipulating TA-TLS as a cancer immunotherapy strategy.
科研通智能强力驱动
Strongly Powered by AbleSci AI